EUVIMEDEUVIMED entdecken
Open Access

IL-33 blockade attenuates vascular inflammation in a mouse model of Kawasaki disease vasculitis

Thacyana T Carvalho, Benjamin L Ross, Prasant K Jena, Asli E Atici, Angela C Gomez, Michael C Fishbein, Emily A Aubuchon, Youngho Lee, Richard T Lee, Elizabeth A Jacobsen, Waldiceu A Verri, Shuang Chen und 3 weitere

Clinical and Experimental Immunology · 2026

DOI: 10.1093/cei/uxaf086 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Experimental Immunology, 2026. Verfasst von Thacyana T Carvalho und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Cedars-Sinai Guerin Children's, Cedars-Sinai Health Sciences University, Los Angeles, CA, USA. Hauptthemen laut MEDLINE: Interleukin-33, Mucocutaneous Lymph Node Syndrome, Vasculitis. Die Arbeit nennt 82 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The immune mechanisms underlying Kawasaki disease (KD), a febrile systemic vasculitis in children, are poorly understood. Reports indicate elevated levels of circulating IL-33 in acute KD patients; however, if IL-33 contributes to the pathogenesis of KD vasculitis remains unclear. Here, we used the Lactobacillus casei cell wall extract (LCWE)-induced murine model of KD to determine the contribution of IL-33 to vasculitis development. We observed increased expression of Il33 transcripts and IL-33 protein in LCWE-induced cardiovascular lesions. Bone marrow chimera experiments suggest that IL-33 production by both hematopoietic and stromal cells is important for LCWE-induced KD vasculitis; however, single-cell RNA sequencing, spatial transcriptomics, and flow cytometric analysis revealed that stromal cells were the predominant sources of IL-33. Furthermore, immune cells infiltrating LCWE-induced cardiovascular lesions expressed Il1rl1 transcripts, coding for the IL-33 receptor ST2. In vitro stimulation of bone marrow-derived macrophages with IL-33 enhanced their production of IL-1b and TNF-α. In vivo blockade of IL-33, using either neutralizing IL-33 antibody or Il33-/- mice, effectively attenuated LCWE-induced cardiovascular inflammation. Our results indicate that IL-33 contributes to LCWE-induced vascular inflammation through redundant mechanisms across multiple immune cell subsets rather than a single population and highlight IL-33 as a potential therapeutic target.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Interleukin-33Mucocutaneous Lymph Node SyndromeVasculitisAnimalsDisease Models, AnimalMiceLacticaseibacillus caseiInterleukin-1 Receptor-Like 1 ProteinHumansInflammationMacrophagesMice, Inbred C57BLMice, Knockout

Stichwörter der Autor:innen

IL-1βIL-33Kawasaki diseasecoronary artery aneurysmvasculitis

Substanzen

Interleukin-33Interleukin-1 Receptor-Like 1 ProteinIl33 protein, mouseIl1rl1 protein, mouse

Autor:innen und Institutionen

  • Department of Pediatrics, Cedars-Sinai Guerin Children's, Cedars-Sinai Health Sciences University, Los Angeles, CA, USA.
  • Infectious and Immunologic Diseases Research Center (IIDRC), Department of Biomedical Sciences, Cedars-Sinai Health Sciences University, Los Angeles, CA, USA.
  • Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
  • Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA.
  • Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
  • Division of Allergy, Asthma and Clinical Immunology, Mayo Clinic Arizona, Scottsdale, AZ, USA.

ORCID-Profile: Magali Noval Rivas

Förderung

  • NIAID NIH HHS
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
  • NIH HHS
  • NIH

Zitieren

APA

Carvalho, T. T., Ross, B. L., Jena, P. K., Atici, A. E., Gomez, A. C., Fishbein, M. C., Aubuchon, E. A., Lee, Y., Lee, R. T., Jacobsen, E. A., Verri, W. A., Chen, S., Crother, T. R., Arditi, M., & Noval Rivas, M. (2026). IL-33 blockade attenuates vascular inflammation in a mouse model of Kawasaki disease vasculitis. Clinical and Experimental Immunology. https://doi.org/10.1093/cei/uxaf086

Vancouver

Carvalho TT, Ross BL, Jena PK, Atici AE, Gomez AC, Fishbein MC, et al. IL-33 blockade attenuates vascular inflammation in a mouse model of Kawasaki disease vasculitis. Clinical and Experimental Immunology. 2026. doi:10.1093/cei/uxaf086

BibTeX
@article{Carvalho2026,
  author = {Carvalho, Thacyana T and Ross, Benjamin L and Jena, Prasant K and Atici, Asli E and Gomez, Angela C and Fishbein, Michael C and Aubuchon, Emily A and Lee, Youngho and Lee, Richard T and Jacobsen, Elizabeth A and Verri, Waldiceu A and Chen, Shuang and Crother, Timothy R and Arditi, Moshe and Noval Rivas, Magali},
  title = {IL-33 blockade attenuates vascular inflammation in a mouse model of Kawasaki disease vasculitis},
  journal = {Clinical and Experimental Immunology},
  year = {2026},
  doi = {10.1093/cei/uxaf086}
}
Kostenlos starten →